Pivotal Therapeutics, a Link Is Discovered between Omega-3 Deficiency and Cardiovascular Disease, CEO Clip Video

Vancouver, British Columbia--(Newsfile Corp. - May 11, 2015) - President & COO, of Pivotal Therapeutics (PVO:CSE, PVTTF:OTCQX) Rachelle MacSweeney explains this emerging specialty pharmaceutical company and their products, Vascazen, Omazen and Benfishial.

If you cannot view the video above, please visit:

http://www.b-tv.com/pivotal-therapeutics-ceo-clip/

About Pivotal Therapeutics (PVO:CSE, PVTTF:OTCQX)

Pivotal Therapeutics Inc. is a publicly traded company with offices in Woodbridge, Ontario Canada and Boca Raton, Florida US. Pivotal is a specialty pharmaceutical company with a focus on Omega-3 therapies for cardiovascular disease (CVD) and overall health. The company currently has two commercial products: VASCAZEN® available in the US by prescription only and OMAZEN® available for sale as a natural health product in Canada. http://www.pivotaltherapeutics.us/

About CEO Clips:

CEO Clips is the largest library of publicly traded company CEO videos in the US and Canada.  These 90 second video profiles broadcast on national TV and are distributed online on top financial portals including: Thomson Reuters, BNN.ca, Stockhouse.com and CBJ.ca.  They are also disseminated via a video news release to several financial portals including Globe Investor, OTC Markets, TMX Money, and The National Post.

BTV — Business Television/CEO Clip Contact: Trina Schlingmann (604) 664-7401 x 5 trina@b-tv.com